The American Journal of Managed Care14h
Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy
Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature ...
The American Journal of Managed Care17h
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm ...
Meet the La Jolla researcher who helped discover new muscular dystrophy drug
Having found that in biomedical research, the Bird Rock resident and scientist at La Jolla’s Sanford Burnham Prebys has ...
Sarcomatrix To Present Preclinical Data On S969 For Duchenne Muscular Dystrophy At MDA Clinical & Scientific Conference
Sarcomatrix Therapeutics Logo RENO, NV, UNITED STATES, March 12, 2025 /EINPresswire / -- Sarcomatrix Therapeutics , a biopharmaceutical compan ...
Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from the Phase 1/2 INSPIRE DUCHENNE ...
Shamrocks MDA, supporting those with muscular dystrophy: Live on GMI
Roland Beres sits down with April Gannon of the Muscular Dystrophy Association to discuss the importance of raising money and ...
Salisbury Post3d
‘They are our heroes’ Annual MDA Festival set to raise money, bring awareness
For the fourth consecutive year, Han-Dee Hugo’s, 1190 Long Ferry Road, Salisbury will be hosting a MDA Festival to raise ...
FDA Approves Expanded Use of Eculizumab (Soliris) for Pediatric Myasthenia Gravis, Bringing New Treatment Options for Children
The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients ...
Advocates Unite in Washington D.C. to Champion Duchenne Policy Reforms
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), with a group of more than 150 advocates, will head to Capitol Hill ...
FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that acceptance has been received by Capricor Therapeutics, Inc. (Headquarters: California, ...
News-Medical.Net4d
Research links kidney dysfunction to muscle weakness in myotonic dystrophy type 1
Thurman M. Wheeler, MD, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in Nature Communications, "Analysis of human urinary extracellular ...
News-Medical.Net7d
Protein cluster discovery could lead to muscular dystrophy treatments
A new discovery about how tiny protein clusters form in cells could pave the way for treatments for Emery-Dreifuss muscular dystrophy (EDMD), a rare genetic disorder that causes muscle weakness and ...